.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Argus Health
Covington
Deloitte
AstraZeneca
Novartis
Mallinckrodt
US Department of Justice
Merck
Cantor Fitzgerald

Generated: July 24, 2017

DrugPatentWatch Database Preview

Betamethasone dipropionate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for betamethasone dipropionate and what is the scope of betamethasone dipropionate patent protection?

Betamethasone dipropionate
is the generic ingredient in eleven branded drugs marketed by Tolmar, Actavis Mid Atlantic, Schering, Taro, Fougera Pharms, Merck Sharp Dohme, Perrigo New York, Glenmark Generics, Pharmaderm, Savage Labs, Fougera, G And W Labs Inc, Fougera Pharms Inc, Teva, Promius Pharma Llc, Alpharma Us Pharms, Leo Pharma As, Perrigo Israel, and Glenmark Pharms, and is included in sixty NDAs. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Betamethasone dipropionate has four patent family members in three countries.

There are sixty-six drug master file entries for betamethasone dipropionate. Twenty-one suppliers are listed for this compound.

Summary for Generic Name: betamethasone dipropionate

Tradenames:11
Patents:8
Applicants:19
NDAs:60
Drug Master File Entries: see list66
Suppliers / Packagers: see list21
Bulk Api Vendors: see list29
Clinical Trials: see list195
Patent Applications: see list3,145
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:betamethasone dipropionate at DailyMed

Pharmacology for Ingredient: betamethasone dipropionate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
OINTMENT;TOPICAL019141-001Sep 4, 1984ABRXYesYes► Subscribe► Subscribe► Subscribe
Leo Pharma As
TACLONEX
betamethasone dipropionate; calcipotriene hydrate
OINTMENT;TOPICAL021852-001Jan 9, 2006ABRXYesYes► Subscribe► Subscribe► Subscribe
Promius Pharma Llc
SERNIVO
betamethasone dipropionate
SPRAY;TOPICAL208079-001Feb 5, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Leo Pharma As
TACLONEX
betamethasone dipropionate; calcipotriene hydrate
SUSPENSION;TOPICAL022185-001May 9, 2008RXYesYes► Subscribe► SubscribeY ► Subscribe
Taro
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
GEL, AUGMENTED;TOPICAL076508-001Dec 2, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: betamethasone dipropionate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme
DIPROLENE AF
betamethasone dipropionate
CREAM, AUGMENTED;TOPICAL019555-001Apr 27, 1987► Subscribe► Subscribe
Schering
DIPROLENE
betamethasone dipropionate
CREAM, AUGMENTED;TOPICAL019408-001Jan 31, 1986► Subscribe► Subscribe
Schering
DIPROLENE
betamethasone dipropionate
GEL, AUGMENTED;TOPICAL019408-002Nov 22, 1991► Subscribe► Subscribe
Merck Sharp Dohme
DIPROLENE
betamethasone dipropionate
OINTMENT, AUGMENTED;TOPICAL018741-001Jul 27, 1983► Subscribe► Subscribe
Merck Sharp Dohme
DIPROLENE
betamethasone dipropionate
LOTION, AUGMENTED;TOPICAL019716-001Aug 1, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: betamethasone dipropionate

Country Document Number Estimated Expiration
Japan5833007► Subscribe
European Patent Office2473161► Subscribe
Japan2013503203► Subscribe
World Intellectual Property Organization (WIPO)2011026076► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Fuji
Accenture
Citi
Harvard Business School
Cerilliant
Federal Trade Commission
Cantor Fitzgerald
US Army
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot